跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,186 条关于
“5-HT2B receptor”
全部
28,186
临床试验
12,891
药物
4,390
机构
1,340
资讯
9,565
上个月
APA 2026: Real-World GAD Treatment Gaps and Preclinical Safety Data for 5-HT2A Agonist DT120
11天前
Deconstructing LSD's ergoline core yields simplified compounds with reduced hallucinogenic and cardiotoxic effects
8个月前
FDA Recommends Second Phase 3 Trial for Reviva's Brilaroxazine in Schizophrenia Treatment
去年
Lundbeck Presents Bexicaserin Data for Developmental and Epileptic Encephalopathies at AES Annual Meeting
去年
Longboard Pharmaceuticals Launches Phase 3 Trial of Bexicaserin for Developmental and Epileptic Encephalopathies
去年
Longboard Pharmaceuticals Initiates Phase III Trial of Bexicaserin for Developmental and Epileptic Encephalopathies
9个月前
Lundbeck's Bexicaserin Shows Sustained Seizure Reduction in Rare Childhood Epilepsies After Two Years of Treatment
2年前
TAK-906: Peripheral D2/D3 Antagonist Under Development for Gastroparesis
2年前
Bright Minds Biosciences Initiates Phase 2 Trial of BMB-101 for Drug-Resistant Epilepsies
去年
atai Life Sciences Secures $11.4 Million NIH Grant for Non-Hallucinogenic Opioid Use Disorder Treatment
第 1 页,共 957 页
上一页
下一页